RSS Feed (xml)

Powered By

Skin Design:
Free Blogger Skins

Powered by Blogger

Monday, June 13, 2016

Dr. Reddy's Laboratories, India's second largest drug maker, has agreed to buy eight generic drugs from Teva Pharmaceutical Industries and Allergan Plc for $350 million in cash to bolster its US business.
Teva Pharmaceutical needs to divest the drugs to win US antitrust clearance for its $40.5bn buyout of Allergan's generic portfolio. The deal includes drugs awaiting US nod and some that are in market, including complex generic products across diverse dosage forms.

1 comment:

Anonymous said...

Nice blog by the way, you can watch out this website in online classified segement,